-
1
Comparative Evaluation of the in-vitro Activity of Six β-lactam/β-lactamase Inhibitor Combinations against Gram Negative Bacilli
Published 2013-02-01Subjects: “…β-lactam/β-lactamase inhibitor combinations…”
Get full text
Article -
2
Vaborbactam increases meropenem susceptibility in Pseudomonas aeruginosa clinical isolates displaying MexXY and AmpC upregulation
Published 2023-10-01Subjects: Get full text
Article -
3
Contribution of efflux pump hyperactivity to the resistance to new β-lactam-β-lactamase inhibitor combinations including ceftazidime-avibactam, aztreonam-avibactam, and imipenem-re...
Published 2024-12-01Subjects: “…β-lactam-β-lactamase inhibitor combinations…”
Get full text
Article -
4
In Vitro Activity of New β-Lactam–β-Lactamase Inhibitor Combinations and Comparators against Clinical Isolates of Gram-Negative Bacilli: Results from the China Antimicrobial Survei...
Published 2022-08-01Subjects: “…β-lactam–β-lactamase inhibitor combinations…”
Get full text
Article -
5
-
6
-
7
-
8
Genome sequencing unveils blaKPC-2-harboring plasmids as drivers of enhanced resistance and virulence in nosocomial Klebsiella pneumoniae
Published 2024-02-01Subjects: “…novel β-lactam/β-lactamase inhibitor combinations…”
Get full text
Article -
9
New Drugs for the Treatment of <i>Pseudomonas aeruginosa</i> Infections with Limited Treatment Options: A Narrative Review
Published 2022-04-01Subjects: “…new β-lactam–β-lactamase inhibitor combinations…”
Get full text
Article -
10
Characterization of Metallo β-Lactamase Producing <i>Enterobacterales</i> Isolates with Susceptibility to the Aztreonam/Avibactam Combination
Published 2024-12-01Subjects: Get full text
Article